Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

CLBT Cellebrite DI Ltd. Class A Ordinary Shares
$12.97 -6.06% -0.83
Notify me if price changes either direction
Interactive Brokers Logotype

Buy CLBT stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 3.2B
Enterprise value 2.8B
Trailing PE 41.774193
Forward PE 21.227072
PEG Ratio 3.34193544
Enterprise to EBITDA 35.941
Enterprise to revenue 5.92
Price to book MRQ 6.647844
Price to sales TTM 6.790867

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2025-12-31
Revenue (TTM) 475.7M
EBITDA 116.6M
Diluted EPS TTM 0.31
Total Cash (MRQ) 437.0M
Current ratio (MRQ) 1.558
Operating Cash Flow (TTM) 173.5M

CLBT trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent CLBT News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.